Research Article

A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling

Figure 5

(a, b) The effect of LMT-28 at optimal concentration on JAK2-STAT3 and GP130 phosphorylation of osteoblasts at different times of stimulation (repeat three times). (c) The effect of dexamethasone and baricitinib on RANKL mRNA expression in osteoblasts. (d, e) The effect of dexamethasone and baricitinib on the expression of RANKL protein and the phosphorylation of JAK2-STAT3 pathway in osteoblasts (repeat three times; , , ).
(a)
(b)
(c)
(d)
(e)